Sohag University Hospital
Sohag, Egypt
Location status: Recruiting
NCT Number: NCT07045857
This study aims to determine recurrence rates, identify influential factors, investigate key factors that contribute to recurrence, evaluate treatment effectiveness and to assess the efficacy of different eradication regimens and their role in reducing recurrence.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Sohag, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence and influential factors for recurrence
Time frame: 4 weeks after successful medical treatment
H. Pylori antigen in stool
Contact information is provided by the study sponsor or research team.
Thomas W Thabet, Resident
CONTACT
Usama M Abdelaal, Professor
CONTACT
Sohag University
Other
Recurrence of H Pylori : Incidence and Influential Factors in Sohag Government.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06529159
H. Pylori Gastrointestinal Disease, H. Pylori Infection
Boston, Massachusetts, United States
View Trial DetailsNCT05387005
H. Pylori Infection
Taipei, Taiwan
View Trial DetailsNCT07045688
H. Pylori Infection
Sohag, Egypt
View Trial DetailsNCT02328131
H. Pylori Infection
Vienna, Austria
View Trial Details